Standout Papers

Entecavir versus Lamivudine for Patients ... 1981 2026 1996 2011 871
  1. Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B (2006)
    Ching‐Lung Lai, Daniel Shouval et al. New England Journal of Medicine
  2. Integration of Hepatitis B Virus DNA into the Genome of Liver Cells in Chronic Liver Disease and Hepatocellular Carcinoma (1981)
    David A. Shafritz, Daniel Shouval et al. New England Journal of Medicine

Immediate Impact

24 by Nobel laureates 28 from Science/Nature 98 standout
Sub-graph 1 of 21

Citing Papers

Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
2 intermediate papers

Works of Daniel Shouval being referenced

Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine
2015
Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines
1994
and 2 more

Author Peers

Author Last Decade Papers Cites
Daniel Shouval 5783 5951 1632 222 8.5k
Arie J. Zuckerman 3781 5000 1449 278 6.9k
Robert Flisiak 5207 5252 1461 350 7.6k
C. Trépo 9202 8875 1220 199 11.0k
R. Palmer Beasley 4763 5813 913 70 7.7k
F. Blaine Hollinger 4518 5331 1708 164 7.8k
Alessandro Zanetti 4503 4650 1364 163 7.0k
Myron J. Tong 10562 10093 1116 261 13.8k
W. Szmuness 4377 5876 1213 72 7.0k
Markus Cornberg 6886 6673 1747 395 10.6k
Michael Roggendorf 3436 4926 1584 223 6.9k

All Works

Loading papers...

Rankless by CCL
2026